In their simulation model, they used data from 4,823 adults in the 2017-2020 National Health and Nutrition Examination Survey (NHANES), representing 126 million eligible U.S
For patients using continuous glucose monitoring (CGM) or regular fingerstick testing, improvements in time in range (glucose levels between 3.910.0 mmol/L) may be observed within days to weeks
The optimistic scenario assumes: Higher weight-loss efficacy, based on emerging data from trials of AOMs Expanded access to the drug, driving higher uptake assumptions Higher persistency, driven by reduced costs and oral forms of the drug and fewer side effects Lower weight regain after stopping the drug Higher non-weight-loss-related mortality impacts The pessimistic scenario, conversely, considers lower efficacy, lower uptake assumptions, higher and quicker weight regain, and lower non-weight-loss-related mortality impacts
Improves how the body handles fat and sugar
Use a separate 3 mL or 5 mL syringe for measuring bacteriostatic water
Cure also offers industry-leading event programming focused on critical health topics